TherapeuticsMD, Inc. (TXMD)Healthcare | Drug Manufacturers - Specialty & Generic | Boca Raton, United States | NasdaqGS
1.97 USD
-0.03
(-1.500%) ⇩
(July 13, 2026, 4 p.m.
EDT)
After hours: 1.90 -0.07 (-0.070%) ⇩ (July 13, 2026, 5:20 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 5:39 a.m. EDT
The investment case for this biotech firm is fundamentally broken. The company has endured a catastrophic multi-year decline, losing nearly 99.7% of its value over the last nine years, with seven consecutive years of negative annual returns. This relentless downward trajectory signals that the market has thoroughly rejected the business model, regardless of recent modest revenue growth or a low forward P/E multiple. The balance sheet is fragile, with negative operating margins and minimal cash reserves relative to the scale of operations, making survival uncertain without external capital. There is no dividend to provide income, and the options market shows zero interest, reflecting a complete absence of speculative hope. While the stock trades at a discount to book value, this is a classic value trap where the price reflects the high probability of further deterioration or delisting rather than a margin of safety. Avoid. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.040598 |
| AutoARIMA | 0.043257 |
| AutoETS | 0.043344 |
| MSTL | 0.046230 |
| MSTL_115 | 0.049686 |
| MSTL_60 | 0.056276 |
| MSTL_60_115 | 0.092811 |
Forecast horizon: 60 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 28% |
| H-stat | 8.38 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.137 |
| Excess Kurtosis | 0.27 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 21.618 |
| Revenue per Share | 0.29 |
| Market Cap | 22,801,494 |
| Trailing P/E | 197.00 |
| Forward P/E | 5.63 |
| Beta | 0.59 |
| Profit Margins | 5.34% |
| Website | https://www.therapeuticsmd.com |
As of July 11, 2026, 5:39 a.m. EDT: Options activity is extremely sparse with negligible open interest and volume across all expirations. Implied volatility is near zero, indicating a lack of speculative positioning or hedging. The absence of significant strikes suggests no clear directional bias from retail or institutional traders.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.7094017 |
| Address1 | 951 Yamato Road |
| Address2 | Suite 220 |
| All Time High | 8,000.0 |
| All Time Low | 0.7 |
| Ask | 2.3 |
| Ask Size | 1 |
| Audit Risk | 9 |
| Average Daily Volume10 Day | 38,630 |
| Average Daily Volume3 Month | 39,811 |
| Average Volume | 39,811 |
| Average Volume10Days | 38,630 |
| Beta | 0.588 |
| Bid | 1.67 |
| Bid Size | 1 |
| Board Risk | 6 |
| Book Value | 2.33 |
| City | Boca Raton |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 6 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.97 |
| Current Ratio | 3.108 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 2.0 |
| Day Low | 1.97 |
| Debt To Equity | 21.618 |
| Display Name | TherapeuticsMD |
| Earnings Timestamp End | 1,755,259,200 |
| Earnings Timestamp Start | 1,754,909,940 |
| Ebitda | -1,407,000 |
| Ebitda Margins | -0.41962 |
| Enterprise To Ebitda | -14.366 |
| Enterprise To Revenue | 6.028 |
| Enterprise Value | 20,213,494 |
| Eps Forward | 0.35 |
| Eps Trailing Twelve Months | 0.01 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 2.0486 |
| Fifty Day Average Change | -0.07859993 |
| Fifty Day Average Change Percent | -0.038367633 |
| Fifty Two Week Change Percent | 70.94017 |
| Fifty Two Week High | 2.95 |
| Fifty Two Week High Change | -0.98 |
| Fifty Two Week High Change Percent | -0.3322034 |
| Fifty Two Week Low | 0.99 |
| Fifty Two Week Low Change | 0.98 |
| Fifty Two Week Low Change Percent | 0.989899 |
| Fifty Two Week Range | 0.99 - 2.95 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,178,717,400,000 |
| Float Shares | 9,491,787 |
| Forward Eps | 0.35 |
| Forward P E | 5.6285715 |
| Free Cashflow | 301,250 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 1 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 1.0 |
| Gross Profits | 3,353,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.074499995 |
| Held Percent Institutions | 0.34006 |
| Implied Shares Outstanding | 11,574,362 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,652,054,400 |
| Last Split Factor | 1:50 |
| Long Business Summary | TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida. |
| Long Name | TherapeuticsMD, Inc. |
| Market | us_market |
| Market Cap | 22,801,494 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_114205175 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | 86,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 22,917,236 |
| Open | 2.0 |
| Operating Cashflow | 2,674,000 |
| Operating Margins | -0.28452998 |
| Overall Risk | 5 |
| Payout Ratio | 0.0 |
| Phone | 561-961-1900 |
| Post Market Change | -0.069900036 |
| Post Market Change Percent | -3.5482252 |
| Post Market Price | 1.9001 |
| Post Market Time | 1,783,977,627 |
| Previous Close | 2.0 |
| Price Hint | 4 |
| Price To Book | 0.8454936 |
| Price To Sales Trailing12 Months | 6.8003263 |
| Profit Margins | 0.053390004 |
| Quick Ratio | 2.502 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.03 |
| Regular Market Change Percent | -1.5 |
| Regular Market Day High | 2.0 |
| Regular Market Day Low | 1.97 |
| Regular Market Day Range | 1.97 - 2.0 |
| Regular Market Open | 2.0 |
| Regular Market Previous Close | 2.0 |
| Regular Market Price | 1.97 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 4,346 |
| Return On Assets | -0.029509999 |
| Return On Equity | 0.0032 |
| Revenue Growth | 0.842 |
| Revenue Per Share | 0.29 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 3 |
| Shares Outstanding | 11,574,362 |
| Shares Percent Shares Out | 0.0049 |
| Shares Short | 56,548 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 51,412 |
| Short Name | TherapeuticsMD, Inc. |
| Short Percent Of Float | 0.0068 |
| Short Ratio | 0.8 |
| Source Interval | 15 |
| State | FL |
| Symbol | TXMD |
| Total Cash | 8,419,000 |
| Total Cash Per Share | 0.727 |
| Total Debt | 5,831,000 |
| Total Revenue | 3,353,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 0.01 |
| Trailing P E | 197.0 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.8918 |
| Two Hundred Day Average Change | 0.07819998 |
| Two Hundred Day Average Change Percent | 0.041336283 |
| Type Disp | Equity |
| Volume | 4,346 |
| Website | https://www.therapeuticsmd.com |
| Zip | 33,431 |